Earlier work demonstrated that miR-320a was a critical target of PTEN in stromal fibroblasts that directly controlled ETS2 expression and instructed the tumor microenvironment to suppress the multiple aggressive phenotypes that are associated with advanced stages of breast cancer, including tumor-cell invasiveness and increased antigenic networks23. The gene discussed is ETS2; the disease is breast carcinoma.